Press Room

Article / Feb 10, 2015

The Time Has Come

PMPS, 2015, February, pp. 30 - 33

The respiratory drug sector is experiencing a surge of interest as companies seek to capitalise on the rapidly growing market.

With new product launches and novel formulation combinations in development, inhaled drug delivery is reaching far beyond its origins in asthma and COPD treatments.


  • Gonçalo Andrade, PhD, Business Development Manager
  • Peter Villax, Vice President of Innovation
  • Carla Vozone, Senior Director, Product Development and Licensing
Read the article here

Also in the Press Room